Peptides for Skin: The Evidence Behind the Big Names

Peptides are the most confidently marketed and least confidently evidenced category in skincare. One peptide has a decent placebo-controlled trial. One has a suggestive trial with a permeation problem. The most famous, copper peptide (GHK-Cu), has a reputation its published human evidence does not support. That is what the literature says when you read it.

The four classes of cosmetic peptide

Cosmetic chemistry sorts peptides by what they are proposed to do, not by what they are made of.

Lupo 2007 - Lupo MP, Cole AL. Cosmeceutical peptides. Dermatol Ther. 2007;20(5):343-9., in the references below described the original taxonomy: “There are three main categories of cosmeceutical peptides: signal peptides, neurotransmitter-affecting peptides and carrier peptides.” A fourth class, enzyme-inhibiting peptides, appears in later reviews. It is a later addition, but marketing copy presents all four as equally settled.

Signal peptides

Signal peptides are proposed to tell fibroblasts to make more matrix. Errante 2020 - Errante F, Ledwoń P, Latajka R et al. Cosmeceutical Peptides in the Framework of Sustainable Wellness Economy. Front Chem. 2020;8:572923., in the references below lists palmitoyl pentapeptide-4 (Matrixyl), PKEK, GEKG and tripeptide-10 citrulline.

Example: Matrixyl (pal-KTTKS). This is the best-evidenced cosmetic peptide I found. Robinson 2005 - Robinson LR, Fitzgerald NC, Doughty DG et al. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. Int J Cosmet Sci. 2005;27(3):155-60., in the references below ran a 12-week double-blind, placebo-controlled, split-face trial: 93 Caucasian women aged 35–55, pal-KTTKS at 3 parts per million. It “provided significant improvement vs. placebo control for reduction in wrinkles/fine lines by both quantitative technical and expert grader image analysis.” The design is good. The caveat is the author affiliation: The Procter & Gamble Company, Miami Valley Laboratories. Industry authorship does not make a result wrong, but independent replication would be worth more than another company study.

Carrier peptides

Carrier peptides are proposed to deliver a trace metal to where enzymes need it. The taxonomy in Errante 2020 - Errante F, Ledwoń P, Latajka R et al. Cosmeceutical Peptides in the Framework of Sustainable Wellness Economy. Front Chem. 2020;8:572923., in the references below names exactly two: copper tripeptide-1 (Cu-GHK) and manganese tripeptide-1 (Mn-GHK). That is the whole class, and copper peptides get the rest of this page.

Neurotransmitter-inhibiting peptides

These are proposed to interfere with muscle contraction at the neuromuscular junction, the “topical Botox” pitch. Errante 2020 - Errante F, Ledwoń P, Latajka R et al. Cosmeceutical Peptides in the Framework of Sustainable Wellness Economy. Front Chem. 2020;8:572923., in the references below lists acetyl hexapeptide-3 (Argireline), pentapeptide-3 (Vialox), pentapeptide-18 (Leuphasyl) and SNAP-8. It notes of Vialox that “there are no further investigations directly describing or enhancing anti-wrinkle properties.”

Example: Argireline. Wang 2013 - Wang Y, Wang M, Xiao S et al. The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled study. Am J Clin Dermatol. 2013;14(2):147-53., in the references below studied 60 Chinese subjects, 3:1 allocation, with twice-daily peri-orbital application for 4 weeks. It reported “total anti-wrinkle efficacy…48.9%, compared with 0% in the placebo group,” with reduced roughness (p<0.01).

Delivery is the problem. Zdrada-Nowak 2025 - Zdrada-Nowak J, Surgiel-Gemza A, Szatkowska M. Acetyl Hexapeptide-8 in Cosmeceuticals-A Review of Skin Permeability and Efficacy. Int J Mol Sci. 2025;26(12)., in the references below, a review that received no external funding, found the permeation literature contradictory. Blanes-Mira and colleagues reported ~30% of an applied 10% formulation penetrating a membrane in 2 hours. Kraeling and colleagues found only 0.22% penetrated the stratum corneum, with none detected in receptor solution at 24 hours. The review concluded: “the transdermal delivery of AH-8 to induce a paralyzing effect in muscles is likely impossible.”

Enzyme-inhibiting peptides

Badilli 2025 - Badilli U, Inal O. Current Approaches in Cosmeceuticals: Peptides, Biotics and Marine Biopolymers. Polymers (Basel). 2025;17(6)., in the references below describes peptides that “directly or indirectly inhibit enzymes, such as MMPs, that contribute to the aging of skin.” Its examples:

• Rice-bran peptides (tyrosinase and hyaluronidase inhibition).
• Silk fibroin/sericin (collagen I and III, antityrosinase).
• Soy oligopeptides (collagen type I gene expression in dermal fibroblasts; reduced UVB erythema).

This evidence is predominantly in vitro and mechanistic, and it comes from a secondary source. Gene expression in a dish is not a wrinkle.

GHK-Cu: what it is, and where the story came from

GHK is a tripeptide: glycyl-L-histidyl-L-lysine. GHK-Cu is that tripeptide complexed with copper. It is a chelate, so the copper is bound, not floating free.

Loren Pickart isolated GHK in 1973. He described it as an activity in human albumin that caused old human liver tissue to synthesize proteins like younger tissue (Pickart 2015 - Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108., in the references below). It started a fifty-year research thread. Pickart 2008 - Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2008;19(8):969-88., in the references below proposes four GHK-Cu mechanisms:

1. Recruitment of repair cells: macrophages and capillary endothelial cells.
2. Anti-inflammatory action, via free-radical suppression and increased antioxidant enzymes.
3. Stimulation of collagen, elastin and growth factor synthesis.
4. Enhanced fibroblast and keratinocyte proliferation.

It is easy to see why the internet loves this molecule. But the framework comes from the originator, not from independent replication. Pickart discovered GHK-Cu and holds commercial interests in it. A mechanism list is a hypothesis about how something might work, not evidence that it does.

The human evidence

The three studies that anchor most consumer claims are not peer-reviewed journal articles. That comes from the reference list of Pickart 2015 - Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108., in the references below, not from my reading. The three are:

• The 71-women facial cream trial: a conference presentation from the American Academy of Dermatology Annual Meeting, February 2002 (Leyden, Stephens, Finkey, Appa, Barkovic).
• The 41-women eye cream trial: a 2002 University of Pennsylvania report.
• The 67-women facial study: a 2005 book chapter.

Author-field searches return only unrelated records: a basophil histamine study (Dvorak 1995 - Dvorak AM, MacGlashan DW Jr, Morgan ES et al. Histamine distribution in human basophil secretory granules undergoing FMLP-stimulated secretion and recovery. Blood. 1995;86(9):3560-6., in the references below) and a décolletage photodamage trial (Leyden 2010 - Leyden JJ, Parr L. Treating photodamage of the décolletage area with a novel copper zinc malonate complex plus hydroquinone and tretinoin. J Drugs Dermatol. 2010;9(3):220-6., in the references below). That is consistent with, but not proof of, the AAD data never having been published in full. Posters are not nothing, but they are not peer review, and they rarely carry the detail needed to check a result.

A widely cited GHK review has a conflict of interest. All three authors of Pickart 2015 - Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108., in the references below share an affiliation with “Skin Biology, Research & Development Department” in Bellevue, WA, a commercial manufacturer and retailer of copper peptide cosmetics. The paper states: “The authors declare that there is no conflict of interests regarding the publication of this paper.” The affiliation block and the declaration do not match.

The published RCT is negative. Miller 2006 - Miller TR, Wagner JD, Baack BR et al. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. Arch Facial Plast Surg. 2006;8(4):252-9., in the references below studied CO2 laser-resurfaced skin over 12 weeks with blinded evaluators and computer image analysis, in 13 completers. Its conclusion: “Copper tripeptide complex (GHK-Cu) skin care products placed on CO2 laser-resurfaced skin offered no significant reduction or resolution of posttreatment erythema. Objective evaluation found no significant improvement in wrinkles or overall skin quality.”

Two details matter:

• Everyone improved in wrinkles and skin quality, whichever arm they were in. What was absent was any between-group difference. That is why uncontrolled before-and-after photos are worthless here.
• The only endpoint favoring GHK-Cu was the patient-reported questionnaire (P = .04), the endpoint most vulnerable to expectation.

Thirteen people is small, and a negative result in 13 is weak evidence of absence. I am not claiming GHK-Cu was proven not to work. This is the published controlled human evidence I could find, and it is one small negative trial. Other GHK-Cu literature exists, including in vitro penetration work on human skin (Hostynek 2011 - Hostynek JJ, Dreher F, Maibach HI. Human skin penetration of a copper tripeptide in vitro as a function of skin layer. Inflamm Res. 2011;60(1):79-86., in the references below) and reviews (Dou 2020 - Dou Y, Lee A, Zhu L et al. The potential of GHK as an anti-aging peptide. Aging Pathobiol Ther. 2020;2(1):58-61., in the references below). The research area is still open.

A 2026 meta-analysis does not mention GHK-Cu at all. Nukaly 2026 - Nukaly HY, Halawani IR, Irtaza HM et al. Oral and topical peptides for skin aging: systematic review and meta-analysis of randomized controlled trials. Front Med (Lausanne). 2026;13:1618306., in the references below pooled 19 RCTs and 1,341 participants on peptides for skin aging and included zero GHK-Cu trials. The string “GHK” and the term “copper tripeptide” appear nowhere in the paper’s full text. Copper appears only as a trace cofactor delivered by carrier peptides and as a micronutrient in two oral collagen drinks. So the review is silent on GHK-Cu and is not evidence against it. The two topical trials it included used Argireline and alpha-defensin-5/beta-defensin-3. The other 17 were oral collagen peptides or hydrolysates.

The paper also says something about all topical peptides: its topical arm was just two studies, against 17 oral. Peptides overall gave what it calls modest yet statistically significant effects. These were limited by inadequate blinding and by heterogeneity running from 84% to 99%, so the pooled numbers read as descriptive rather than precise.

Formulation reality: does it even get in?

As far as I can tell, nobody has resolved whether GHK-Cu gets through skin.

From PubChem (CID 73587), GHK is C14H24N6O4: molecular weight 340.38 Da, computed XLogP −4.4, topological polar surface area 176 Ų, 6 hydrogen-bond donors, 7 acceptors.

Compare that with the rule of thumb everyone quotes. Bos 2000 - Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol. 2000;9(3):165-9., in the references below proposed that molecules must be under 500 Da to penetrate the corneal layer. The case rested on three lines of evidence:

• Virtually all common contact allergens are under 500 Da.
• Common topical dermatological drugs are under 500 Da.
• “All known topical drugs used in transdermal drug-delivery systems are under 500 Dalton.”

At 340 Da, GHK clears that bar. Two caveats follow. Bos and Meinardi wrote an argument paper, not an experimental study. The rule is a heuristic, not a measured physical limit, so passing it makes penetration plausible without proving it. And molecular weight is only one variable. The stratum corneum is a lipid barrier, and an XLogP of −4.4 with a TPSA of 176 Ų describes an extremely hydrophilic, highly polar molecule. Those properties do not obviously favor crossing a lipid barrier by passive diffusion. That is an inference from computed descriptors, not a finding: PubChem reports chemistry and says nothing about permeation.

The vitamin C layering question

This is internet lore with a plausible chemical rationale and no direct evidence. Separating the two serums AM/PM is a low-cost hedge, not an evidence-based rule. Both of the usual answers are wrong.

“It’s a myth, layer freely” is wrong. PubMed indexes no clinical or in vivo study of GHK-Cu and vitamin C applied topically together, and the null holds across several query formulations. But no topical study does not mean no mechanism. Older laboratory work reported that ascorbate plus a copper-tripeptide complex cleaved DNA and proteins while neither did so alone. Copper-catalyzed ascorbate oxidation is also well-documented solution chemistry more broadly. Neither is in my source registry, so I cannot give a checkable reference for them and you should treat them as leads rather than citations. Both are decades-old test-tube chemistry, not a face.

“It’s proven harmful, never combine” is also wrong. Nothing has been shown to happen on skin. I could not find a source measuring what the combination does on skin, in either direction.

Three genuine unknowns sit underneath this:

• GHK-Cu is a chelate. The copper is bound, not free, and chelation materially alters redox behavior. Extrapolating free-Cu²⁺ chemistry to a chelate is an inference. I found no study measuring this for GHK-Cu specifically, and it is the crux of the question.
• The pH argument. The claim is that L-ascorbic acid at pH ~2.5–3.5 destabilizes the complex and liberates free copper. I found it only in brand and blog sources, with no primary measurement in a skin context.
• Contact is assumed, not shown. Nobody has tested whether two serums applied minutes apart co-mingle on skin at concentrations where any of this would matter.

If you want to separate them, separate them. It costs nothing but a little routine complexity. Just don’t let anyone tell you, me included, that the science is settled.

Where peptides sit versus retinoids

Peptides are not a substitute for a retinoid, and the evidence shows why.

Sitohang 2022 - Sitohang IBS, Makes WI, Sandora N et al. Topical tretinoin for treating photoaging: A systematic review of randomized controlled trials. Int J Womens Dermatol. 2022;8(1):e003., in the references below systematically reviewed topical tretinoin for photoaging: 7 randomized controlled trials, 739 subjects. “All studies consistently reported that topical tretinoin was efficacious in improving clinical appearance of photoaging in terms of wrinkling, mottled hyperpigmentation, sallowness, and lentigines.” Improvements appeared after 4 months and persisted to 24 months. It was a systematic review without meta-analysis, so there is no pooled effect size to quote. The concentrations it covered ran 0.025%–5%.

Tretinoin has 7 RCTs and 739 subjects with consistent findings. GHK-Cu has one small negative RCT. That is not a close contest, which is why my position is that peptides are adjuncts. A retinoid is the better-supported place to spend money and skin tolerance. A peptide serum is what you add around it, not instead of it.

What to look for

The useful advice here is short and mostly negative.

• Prefer the peptide with the trial. For a peptide serum with an actual placebo-controlled human study behind it, Matrixyl (palmitoyl pentapeptide-4) is the one. Industry-authored evidence is still evidence.
• Treat copper peptides as an experiment you are running on yourself. If you use them, you are outside the published efficacy evidence.
• Ignore the percentage arms race. With no human dose-response data, “7% copper peptide” is a marketing number, not a dosing decision.
• Ignore before-and-after photos. Miller 2006 - Miller TR, Wagner JD, Baack BR et al. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. Arch Facial Plast Surg. 2006;8(4):252-9., in the references below is the reason: everyone improved in both arms.
• Read the claim language. Under 21 U.S.C. §321 a cosmetic “alters the appearance,” while an article “intended to affect the structure or any function of the body” is a drug. Both turn on intended use, which is why serums talk about the look of fine lines rather than collagen synthesis.
• Sunscreen and a retinoid first. Peptides are the third thing, not the first.

For a walk-through of specific products in this category, see my best peptide serums breakdown.

Common questions

Do copper peptides actually work?

I do not know. The three human studies most often quoted for GHK-Cu were never published as peer-reviewed journal articles: a 2002 conference presentation, a 2002 university report and a 2005 book chapter. I found one published randomized controlled trial: Miller 2006, in 13 people with laser-resurfaced skin. By objective measures it found no significant difference between GHK-Cu and control on erythema, wrinkles or overall skin quality. A 2026 meta-analysis of 19 peptide trials and 1,341 participants included zero GHK-Cu studies and never mentions GHK-Cu, so it is silent on copper peptides rather than evidence against them.

Can copper peptides even get through the skin?

This has apparently never been settled in living human skin. GHK has a molecular weight of 340 daltons, under the 500-dalton rule of thumb proposed by Bos and Meinardi in 2000. But it is also extremely water-loving and highly polar (a computed XLogP of about minus 4.4 and a polar surface area of 176 square angstroms). The stratum corneum is a lipid barrier. Size is permissive, polarity is not. In vitro work on excised human skin exists, but I could not find a human in vivo penetration study that resolves the question.

Should I avoid using copper peptides with vitamin C?

Nobody has tested it on skin. PubMed indexes no clinical or in vivo study of GHK-Cu and vitamin C applied topically together. The caution is not pure folklore: older laboratory work reported that ascorbate plus a copper-tripeptide complex cleaved DNA and proteins when neither did so alone. That work is not in my source registry, so I cannot give a checkable reference for it, and a test tube is not a face. Separating them into morning and evening is a cheap hedge, not an evidence-based rule. Confident claims in either direction are unsupported.

Which cosmetic peptide has the best evidence?

Matrixyl, also called palmitoyl pentapeptide-4 or pal-KTTKS. Robinson and colleagues ran a 12-week double-blind, placebo-controlled, split-face trial in 93 women aged 35 to 55 using 3 parts per million. They reported significant improvement versus placebo for reduction in wrinkles and fine lines by both quantitative image analysis and expert graders. The caveat is that the study was authored by Procter and Gamble at its Miami Valley Laboratories.

Are peptides a replacement for retinoids?

No. A 2022 systematic review by Sitohang and colleagues covered 7 randomized controlled trials of topical tretinoin in 739 subjects. All consistently reported improvement in wrinkling, mottled hyperpigmentation, sallowness and lentigines. GHK-Cu has one small published randomized trial, and it was negative. Peptides are best treated as adjuncts to a routine, not substitutes for a retinoid.

Are peptide serums FDA-approved?

No. Peptide serums are sold as cosmetics, and cosmetics are not FDA-approved before sale. Under 21 U.S.C. 321(i) a cosmetic is an article applied to the body for cleansing, beautifying or altering the appearance. Under 21 U.S.C. 321(g)(1) an article intended to affect the structure or any function of the body is a drug. Both definitions turn on intended use, which is why product labels describe appearance rather than biology.

References (18 sources)

Show

Bibliographic detail is fetched from PubMed, not written by me - so a citation here cannot drift from the paper it names. Study design comes from PubMed's own tags rather than my judgement.

1. 1.Badilli U, Inal O. Current Approaches in Cosmeceuticals: Peptides, Biotics and Marine Biopolymers. Polymers (Basel). 2025;17(6).ReviewPMID 40292641full text
2. 2.Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol. 2000;9(3):165-9.ReviewPMID 10839713
3. 3.Dou Y, Lee A, Zhu L et al. The potential of GHK as an anti-aging peptide. Aging Pathobiol Ther. 2020;2(1):58-61.StudyPMID 35083444full text
4. 4.Dvorak AM, MacGlashan DW Jr, Morgan ES et al. Histamine distribution in human basophil secretory granules undergoing FMLP-stimulated secretion and recovery. Blood. 1995;86(9):3560-6.StudyPMID 7579464
5. 5.Errante F, Ledwoń P, Latajka R et al. Cosmeceutical Peptides in the Framework of Sustainable Wellness Economy. Front Chem. 2020;8:572923.ReviewPMID 33195061full text
6. 6.Hostynek JJ, Dreher F, Maibach HI. Human skin penetration of a copper tripeptide in vitro as a function of skin layer. Inflamm Res. 2011;60(1):79-86.StudyPMID 20721598full text
7. 7.Leyden JJ, Parr L. Treating photodamage of the décolletage area with a novel copper zinc malonate complex plus hydroquinone and tretinoin. J Drugs Dermatol. 2010;9(3):220-6.Randomised trialPMID 20232582
8. 8.Lupo MP, Cole AL. Cosmeceutical peptides. Dermatol Ther. 2007;20(5):343-9.ReviewPMID 18045359
9. 9.Miller TR, Wagner JD, Baack BR et al. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. Arch Facial Plast Surg. 2006;8(4):252-9.Randomised trialPMID 16847171
10. 10.Nukaly HY, Halawani IR, Irtaza HM et al. Oral and topical peptides for skin aging: systematic review and meta-analysis of randomized controlled trials. Front Med (Lausanne). 2026;13:1618306.Systematic reviewPMID 41924746full text
11. 11.Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2008;19(8):969-88.ReviewPMID 18644225
12. 12.Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108.ReviewPMID 26236730full text
13. 13.Robinson LR, Fitzgerald NC, Doughty DG et al. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. Int J Cosmet Sci. 2005;27(3):155-60.StudyPMID 18492182
14. 14.Sitohang IBS, Makes WI, Sandora N et al. Topical tretinoin for treating photoaging: A systematic review of randomized controlled trials. Int J Womens Dermatol. 2022;8(1):e003.ReviewPMID 35620028full text
15. 15.Wang Y, Wang M, Xiao S et al. The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled study. Am J Clin Dermatol. 2013;14(2):147-53.Randomised trialPMID 23417317
16. 16.Zdrada-Nowak J, Surgiel-Gemza A, Szatkowska M. Acetyl Hexapeptide-8 in Cosmeceuticals-A Review of Skin Permeability and Efficacy. Int J Mol Sci. 2025;26(12).ReviewPMID 40565185full text
17. 17.PubChem CID 73587 - GHK computed properties (formula, molecular weight, XLogP, TPSA, H-bond donors and acceptors)- National Center for Biotechnology Informationdatabase
18. 18.21 U.S.C. §321 - Federal Food, Drug, and Cosmetic Act definitions of "cosmetic" (§321(i)) and "drug" (§321(g)(1))- Cornell Law School Legal Information Institutestatute

Keep reading

Related guides

All guides →

• best peptide serumBest Peptide Serums and Copper Peptide Serums, ComparedThe best peptide serums by human evidence: palmitoyl pentapeptide-4, Argireline and 1% copper peptide picks, with prices as of 3 October 2026.12 min readRead guide→
• argirelineArgireline (Acetyl Hexapeptide-8): The Study EvidenceArgireline is sold as a topical Botox alternative. What the randomised cosmetic studies measured, how large the changes were, and where the comparison breaks down.1 min readRead guide→
• matrixylMatrixyl (Palmitoyl Pentapeptide): The EvidenceWhat the cosmetic clinical research on Matrixyl measured, how the trade-name family differs, and why the studies do not transfer to every cream that names it.1 min readRead guide→
• ghk peptideGHK Peptide: GHK vs GHK-Cu ExplainedThe free tripeptide and the copper complex are sold under one name and studied differently. What separates them, and where the marketing overreaches.3 min readRead guide→
• copper peptidesGHK-Cu (Copper Peptides): Benefits, Dosage, Side EffectsGHK-Cu (copper peptides): what the research shows, typical cosmetic concentrations, side effects users report, and how legal status works for a cosmetic ingredient.5 min readRead guide→
• ghk cu dosageGHK-Cu Dosage Chart and Calculator: Cosmetic and Study DosesGHK-Cu dosage chart: units per dose by vial size, a calculator, the under-10-ppm cosmetic concentration, and what published topical studies used.4 min readRead guide→